http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012502951-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012502951-A
titleOfInvention 3,4-Dihydro-2H-pyrrolo [1,2-a] pyrazin-1-one derivatives
abstract Compounds that are 4,7-disubstituted derivatives of 3,4-dihydro-2H-pyrrolo [1,2-a] pyrazin-1-one compounds, or pharmaceutically acceptable salts thereof, methods for their preparation and A pharmaceutical composition comprising these is disclosed. These compounds may be caused by and / or associated with alterations in protein kinase activity such as cancer, viral infection, prevention of AIDS in individuals infected with HIV, cell proliferation disorders, autoimmunity and neurodegenerative disorders. Useful for treatment. Also disclosed are methods of preparing the compounds of the invention under solid phase synthesis conditions and chemical libraries comprising a plurality of these compounds.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013518072-A
priorityDate 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008057512-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008052964-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007042784-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006052913-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466251797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466251795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467794168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467794154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471665400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471665399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467384202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471630438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471630437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471630436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466251800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466251798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466405427

Total number of triples: 49.